MARKET NEWS

ChemoCentryx & VFMCRP Announce Positive Topline Data From Pivotal Phase 3 Trial
Avadel Pharmaceuticals Achieves Enrollment Target in REST-ON Phase 3 Pivotal Trial
TFF Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial
Yourway Announces Opening of New Wholly Owned Depot in India
Inceptua & Bendalis Enter Exclusive Agreement
Akcea & Ionis Announce Initiation of NEURO-TTRansform Phase 3 Clinical Trial 

  FEATURED EDITORIAL

  COMPANY PROFILE

ARL Bio Pharma is a contract laboratory that provides analytical and microbiological testing to pharmaceutical companies and research scientists. Our laboratory is headquartered in Oklahoma City, Oklahoma, and serves over 3,000 clients nationwide. Since 1998, ARL has supported the industry-wide commitment to deliver high-quality therapeutic drug products by providing guidance and test services for all phases of the product lifecycle following USP, FDA, and ICH guidelines. Whether you are an innovator or pharmaceutical manufacturer, we provide the testing needed to get your pharmaceutical products to market. ARL’s dedicated team oversees the entire process from understanding your product goals to providing results and helping interpret the data. ARL is FDA registered and audited, ISO 17025 accredited and DEA licensed for Schedules I through V. Our laboratory maintains programs that support continuous improvement yielding over 20 years of quality service through experience and excellence. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Recipharm Announces Commercial Manufacturing to Support Drug Launch Following FDA Approval

Recipharm Announces Commercial Manufacturing to Support Drug Launch Following FDA Approval

Recipharm, the contract development and manufacturing organisation (CDMO), recently announced ongoing large-scale commercial manufacturing of RedHill Biopharma’s drug, Talicia (omeprazole magnesium,…..

PPD Expands Special Patient Capabilities in Early Development Research

PPD Expands Special Patient Capabilities in Early Development Research

PPD, Inc. has expanded its early development research services by adding significant neuroscience and ethno-bridging expertise, broadening its capabilities to provide increased access to…..

Encouraging Results of Pilot Study Testing Bionic Pancreas

Encouraging Results of Pilot Study Testing Bionic Pancreas

Beta Bionics, Inc., a medical technology company developing and aiming to commercialize the world’s first fully automated bionic pancreas, recently announced its bionic pancreas glucose control algorithms that use lifelong autonomous learning were deployed in….

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

December 11 – Controlled Release
December 18 – Parenteral Contract Manufacturing